Tumor strengths and frailties: Cancer SUMmOns Otto's metabolism.
University of Toronto, Toronto, Ontario, Canada. michael.ohh@utoronto.ca
Michael
M
Ohh
D000332:Aerobiosis; D000693:Anaerobiosis; D002292:Carcinoma, Renal Cell / Q000235:genetics*; D049109:Cell Proliferation; D002471:Cell Transformation, Neoplastic / Q000235:genetics / Q000378:metabolism*; D004734:Energy Metabolism / Q000235:genetics; D015972:Gene Expression Regulation, Neoplastic; D018095:Germ-Line Mutation; D006019:Glycolysis / Q000235:genetics; D006801:Humans; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000235:genetics / Q000378:metabolism; D007680:Kidney Neoplasms / Q000235:genetics* / Q000378:metabolism; D008545:Melanoma / Q000235:genetics*; D051739:Microphthalmia-Associated Transcription Factor / Q000235:genetics* / Q000378:metabolism; D024101:Mitochondrial Proteins / Q000378:metabolism; D025842:SUMO-1 Protein / Q000235:genetics* / Q000378:metabolism; D012871:Skin Diseases / Q000235:genetics* / Q000378:metabolism; D013385:Succinate Dehydrogenase / Q000235:genetics
C497442:HIF1A protein, human; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; C497234:MITF protein, human; D051739:Microphthalmia-Associated Transcription Factor; D024101:Mitochondrial Proteins; C543341:SDHAF2 protein, human; D025842:SUMO-1 Protein; D013385:Succinate Dehydrogenase